Skip to main content
SpringerLink
Log in

Comment on: “The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review”

  • Letter to the Editor
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

The Original Article was published on 17 July 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vondeling GT, Cao Q, Postma MJ, Rozenbaum MH. The impact of patent expiry on drug prices: a systematic literature review. Appl Health Econ Health Policy. 2018;16(5):653–60. https://doi.org/10.1007/s40258-018-0406-6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chaves GC, Oliveira MA, Hasenclever L, de Melo LM. Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines. Cad Saude Publica. 2007;23(2):257–67. https://doi.org/10.1590/S0102-311X2007000200002.

    Article  PubMed  Google Scholar 

  3. World Health Organization. Medicine availability of selected generic medicines. 2015. http://www.who.int/gho/mdg/medicines/availability/en/.

  4. Diependaele L, Cockbain J, Sterckx S. Raising the barriers to access to medicines in the developing world—the relentless push for data exclusivity. Dev World Bioeth. 2017;17(1):11–21. https://doi.org/10.1111/dewb.12105.

    Article  PubMed  Google Scholar 

  5. Hug SE, Brändle MP. The coverage of Microsoft Academic: analyzing the publication output of a university. Scientometrics. 2017;113(3):1551–71. https://doi.org/10.1007/s11192-017-2535-3.

    Article  Google Scholar 

  6. Thelwall M. Microsoft Academic: a multidisciplinary comparison of citation counts with Scopus and Mendeley for 29 journals. J Informetr. 2017;11(4):1201–12. https://doi.org/10.1016/j.joi.2017.10.006.

    Article  Google Scholar 

  7. Haunschild R, Hug SE, Brändle MP, Bornmann L. The number of linked references of publications in Microsoft Academic in comparison with the web of science. Scientometrics. 2018;114(1):367–70. https://doi.org/10.1007/s11192-017-2567-8.

    Article  Google Scholar 

  8. Punjabi SS, Johnsrud MT, Conner C. Economic impact of Prozac® patent expiration and the 180-day generic fluoxetine exclusivity in a publicly-financed prescription program. Val Health. 2003;6(3):192. https://doi.org/10.1016/S1098-3015(10)63837-5.

    Article  Google Scholar 

  9. Keele MG, Butkow N, Venter D. Beyond patent expiry: development of a model for pricing generic drugs in South Africa. Val Health. 2013;16(7):A466. https://doi.org/10.1016/j.val.2013.08.828.

    Article  Google Scholar 

  10. Riku J. Current situation for generic drugs in Japan. J Generic Medicines. 2005;2(3):219–31. https://doi.org/10.1057/palgrave.jgm.4940073.

    Article  Google Scholar 

  11. Oh KY, Kim B, Kim T. Estimating market share function of generic drugs after patent expiration in Korea. Kor J Health Econ Policy. 2007;13(1):117–38.

    Google Scholar 

  12. Adriaen M, De Witte K, Simoens S. Pricing strategies of originator and generic medicines following patent expiry in Belgium. J Generic Med. 2008;5(3):175–87. https://doi.org/10.1057/jgm.2008.8.

    Article  Google Scholar 

  13. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12. https://doi.org/10.1016/j.jclinepi.2009.06.005.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CENTRUM Católica Graduate Business School (CCGBS), Jirón Daniel Alomía Robles 125, Lima 33, Peru

    Carlos Vílchez-Román

  2. Pontificia Universidad Católica del Perú (PUCP), Av. Universitaria 1801, Lima 32, Peru

    Carlos Vílchez-Román

  3. School of Communications, Universidad de Lima (ULima), Javier Prado Este Cuadra 46 S/N, Lima 33, Peru

    Sol Sanguinetti

  4. Environment and Technology Institute (ETI), Jirón Bach BH2, Lima 33, Peru

    Sol Sanguinetti

  5. Centro de Excelencia en Estudios Económicos y Sociales en Salud, Universidad San Ignacio de Loyola (USIL), Avenida La Fontana 550, Lima, Peru

    Edward Mezones-Holguín

  6. Epi-gnosis Solutions, Santiago Távara 174, Piura, Peru

    Edward Mezones-Holguín

Authors
  1. Carlos Vílchez-Román
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sol Sanguinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward Mezones-Holguín
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Vílchez-Román.

Ethics declarations

Conflict of Interest

We, Carlos Vílchez-Román, Sol Sanguinetti and Edward Mezones-Holguín declare no potential conflict of interest with respect to the research, authorship, and/or publication of this article. For this article, Carlos Vílchez-Román received funding from CENTRUM Católica Graduate Business School (CCGBS), and Sol Sanguinetti received funding from Universidad de Lima (ULima).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vílchez-Román, C., Sanguinetti, S. & Mezones-Holguín, E. Comment on: “The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review”. Appl Health Econ Health Policy 17, 255–256 (2019). https://doi.org/10.1007/s40258-018-0441-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40258-018-0441-3

Search

Navigation